comparemela.com

Latest Breaking News On - Altamira therapeutics ltd - Page 1 : comparemela.com

Altamira Shareholders Approve Key Corporate Changes

Altamira Therapeutics Ltd. (CYTO) has released an update. At the recent Annual General Meeting, Altamira Therapeutics Ltd. shareholders elected fou.

Altamira therapeutics ltdAltamira therapeuticsAnnual general meeting

Altamira Therapeutics Ltd (NASDAQ:CYTO) Sees Significant Growth in Short Interest

Altamira Therapeutics Ltd (NASDAQ:CYTO) Sees Significant Growth in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Armistice capitalAltamira therapeutics ltdAltamira therapeuticsGet free reportFree reportAltamira therapeutics daily

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

01.05.2024 - Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) - Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira . Seite 1

United statesCovadonga paUnited states patent officeCompany nasdaqDevelopment officerCompany oligophoreAltamira therapeutics ltdAltamira therapeuticsAltamira therapeutic chief development

Altamira Therapeutics (CYTO) Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Altamira Therapeutics (CYTO) Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas meyerEuropean academy of allergyAltamira therapeutics ltdCompany nasdaqEuropean academyClinical immunologyTotal nasal symptom scoreRhinoconjunctivitis qualityLife questionnaireAltamira medicaAltamira therapeutics

Altamira Therapeutics Announces Publication of Positive

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis.

Company nasdaqSecurities exchangeAltamira therapeutics ltdEuropean academy of allergySecurities exchange commissionEuropean academyClinical immunologyTotal nasal symptom scoreRhinoconjunctivitis qualityLife questionnaireAbout altamiraAltamira medicaSecurities actSecurities exchange actAnnual reportNasdaq cyto

vimarsana © 2020. All Rights Reserved.